Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes

PURPOSE: To investigate the efficacy, safety, and anatomical outcomes associated with intravitreal anti-vascular endothelial growth factor (VEGF) treatment of retinopathy of prematurity (ROP). METHODS: We performed a retrospective review of intravitreal anti-VEGF (bevacizumab or ranibizumab) treatme...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Korean J Ophthalmol
Hoofdauteurs: Kang, Hyun Goo, Choi, Eun Young, Byeon, Suk Ho, Kim, Sung Soo, Koh, Hyoung Jun, Lee, Sung Chul, Kim, Min
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Korean Ophthalmological Society 2018
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6288015/
https://ncbi.nlm.nih.gov/pubmed/30549468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3341/kjo.2018.0011
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items